Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
PharmAbcine Inc.
About
  2. Companies
  3. PharmAbcine Inc.
  4. Products
  5. PharmAbcine - Model PMC-403 - ...

PharmAbcine - Model PMC-403 -Monoclonal Antibody

SHARE

PMC-403 is a monoclonal antibody that targets the human TIE2 that regulate the angiogenesis and vessel maturation in endothelial cells. It binds to TIE2 expressing endothelial cells and normalize VEGF-induced pathological leaky blood vessels in eyes and TME (tumor microenvironment).

Most popular related searches
monoclonal antibody
solid tumor
tumor microenvironment
diabetes retinopathy
macular degeneration
blood vessel
degeneration diabetic
tumor modeling
vascular endothelial growth factor
retinopathy
  • Ophthalmology / Solid tumors
  • PMC-403 was tested in various vessel-related diseases, such as AMD (Age-related Macular Degeneration), DR (Diabetic Retinopathy), and even solid tumors. In these models, significant vessel normalizing effects were found which suggest versatile use in a wide range of indications. PharmAbcine initiated the GLP-tox study of PMC-403 in 2Q21 and expects an IND filing in 3Q22.